Unlocking a Combination Therapy for New Onset T1D

Next month, a new study will start to further assess if a novel combination of drugs could help treat new onset type 1 diabetes University of Florida researchers are ready to launch a new clinical study to examine if a combination of two U.S Food and Drug Administration (FDA) approved drugs, antithymocyte globulin (ATG) and […]

A song worth more than a listen

Korn releases exclusive download to benefit T1D research What can one voice raised against type 1 diabetes (T1D) do? If you’re Jonathan Davis, lead singer of acclaimed rock band Korn, one voice can reach millions to help people living with T1D. Jonathan’s young son, Zeppelin, was diagnosed with T1D just over a year ago, and […]

Advancing a Key Artificial Pancreas Technology

Stable liquid glucagon developed by JDRF partner Xeris evaluated in first clinical study The JDRF Artificial Pancreas (AP) project is focused on accelerating the development of commercially-viable AP systems that better mimic the biological function of the pancreas and reduce the daily burden of managing type 1 diabetes (T1D). To achieve this goal, JDRF funds […]

Improving Beta Cell Health and Survival

JDRF-funded clinical study to test marketed drug to improve beta cell health and survival in T1D JDRF recently awarded a $2.1 million grant to Anath Shalev, M.D., director of the University of Alabama’s (UAB) Comprehensive Diabetes Center, to test the impact of a common blood pressure drug called verapamil on the health and survival of […]

Historic Progress for JDRF Encapsulation Research Program

First people with type 1 diabetes receive experimental encapsulated cell replacement therapies in clinical studies Two JDRF-funded partners have successfully implanted people with type 1 diabetes (T1D) with experimental encapsulated cell replacement therapies in clinical studies. These two programs are running in parallel and are evaluating two distinct encapsulation therapies. Encapsulated cell replacement therapy involves […]

Making the T1D Vaccine a Reality

Nanoparticle-based vaccine is designed to re-educate the immune system and halt the attack on the pancreas Over the last three years, Selecta Bioscience, a clinical stage biotechnology company, has been developing nanoparticles called Synthetic Vaccine Particle (SVP) as an immunotherapy for Type 1 diabetes (T1D) with support from JDRF and it was announced this week […]

JDRF-Funded Research Leads to Beta Cell Replacement Breakthrough

A new method for converting stem cells to beta cells could speed encapsulated cell replacement product development and research to cure type 1 diabetes Insulin therapy has long been the only method of treating type 1 diabetes (T1D), but a major breakthrough in producing replacement beta cells is bringing new hope that more effective, alternative […]

FAMILY TEAM SPOTLIGHT: Team Cake-Cake

FAMILY TEAM SPOTLIGHT: Team Cake-Cake

FAMILY TEAM SPOTLIGHT: Team Cake-Cake Piper was diagnosed October 2011 at 16 months old. She is now 4 years old and loves to sing and dance. The team name, Team Cake-Cake, came about because cupcakes are one of Piper’s favorite things and her family likes to raise awareness that yes, she can eat that! Team […]

Shout-out to New Teams Raising over $500…

We’d like to give a quick shout-out to our New Walk Teams who have raised over $500 to date:  Jack’s Sugar Shakers ($2,220), Corin Thunderfist ($1,940), Team Slaughter ($1,300), Claire’s Cure ($1,175), Kure for Kie ($1,124), “D” SCORSONE ($930), Big Shots ($690) and Team Knockout ($514).  Keep up the fundraising! We have almost raised $95,000 […]

FAMILY TEAM SPOTLIGHT: T1D Super Brothers

FAMILY TEAM SPOTLIGHT: T1D Super Brothers

FAMILY TEAM SPOTLIGHT: T1D Super Brothers Tyler Winters was diagnosed with T1D at 2 1/2 in October 2011, and his first Walk was in 2012. Tyler and his family were blown away by the emotional impact it had because for the first time in almost a year they didn’t feel alone. It gave them a […]